[HTML][HTML] Glucagon-like peptide 1 (GLP-1)

TD Müller, B Finan, SR Bloom, D D'Alessio… - Molecular …, 2019 - Elsevier
Background The glucagon-like peptide-1 (GLP-1) is a multifaceted hormone with broad
pharmacological potential. Among the numerous metabolic effects of GLP-1 are the glucose …

The new biology and pharmacology of glucagon

TD Müller, B Finan, C Clemmensen… - Physiological …, 2017 - journals.physiology.org
In the last two decades we have witnessed sizable progress in defining the role of
gastrointestinal signals in the control of glucose and energy homeostasis. Specifically, the …

The role of incretins in glucose homeostasis and diabetes treatment

W Kim, JM Egan - Pharmacological reviews, 2008 - ASPET
Incretins are gut hormones that are secreted from enteroendocrine cells into the blood within
minutes after eating. One of their many physiological roles is to regulate the amount of …

The metabolic actions of glucagon revisited

KM Habegger, KM Heppner, N Geary… - Nature Reviews …, 2010 - nature.com
The initial identification of glucagon as a counter-regulatory hormone to insulin revealed this
hormone to be of largely singular physiological and pharmacological purpose. Glucagon …

The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily

NM Sherwood, SL Krueckl, JE McRory - Endocrine reviews, 2000 - academic.oup.com
The pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily
includes nine hormones in humans that are related by structure, distribution (especially the …

Regulation of gene expression by insulin

RM O'Brien, DK Granner - Physiological reviews, 1996 - journals.physiology.org
While insulin has long been known to modulate intracellular metabolism by altering the
activity or intracellular location of various enzymes, it is only in the past 10 years that the …

Glucagon, from past to present: a century of intensive research and controversies

AJ Scheen, PJ Lefèbvre - The Lancet Diabetes & Endocrinology, 2023 - thelancet.com
Summary 2022 corresponds to the 100th anniversary of the discovery of glucagon. This
TimeCapsule aims to recall the main steps leading to the discovery, characterisation, and …

Minireview: the Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus

T Jin, L Liu - Molecular endocrinology, 2008 - academic.oup.com
Since the relationship between TCF7L2 (also known as TCF-4) polymorphisms and type 2
diabetes mellitus was identified in 2006, extensive genome-wide association examinations …

The WNT signalling pathway and diabetes mellitus

T Jin - Diabetologia, 2008 - Springer
The WNT signalling pathway is involved in many physiological and pathophysiological
activities. WNT ligands bind to Frizzled receptors and co-receptors (LDL receptor-related …

[HTML][HTML] Glucagon's metabolic action in health and disease

A Zeigerer, R Sekar, M Kleinert, S Nason… - Comprehensive …, 2021 - ncbi.nlm.nih.gov
Discovered almost simultaneously with insulin, glucagon is a pleiotropic hormone with
metabolic action that goes far beyond its classical role to increase blood glucose. Albeit best …